Gene splicing could improve pharma understanding of human genome
Jan 21 2011
Writing in genomics methodology and new research periodical Genome Biology, researchers from INRAN and the Sapienza Universita di Roma explain that many transcripts associated with alternatively spliced protein-coding genes cannot be linked directly with a specific functional protein.
This is in spite of the belief that spliced genes are the explanation for why the genomic sequence appears to be transcribed to an order of magnitude beyond that possible with predicted and characterised genes.
Mass spectrometry allowed alternative splicing human gene isoforms to be analysed for the plausibility of their predicted structure, the presence of uninterrupted functional domains and any active sites.
It is the latter point - and the conservation of those active sites - that offers the best opportunity for pharma researchers to correctly identify translated products, the team concludes.
In This Edition Modern & Practocal Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Oct 10 2023 Hybrid event
Oct 15 2023 Katowice, Poland
Nov 05 2023 Vienna, Austria
Nov 12 2023 Louisville, KY, USA
Nov 13 2023 Plainsboro, NJ, USA